BusinessOrganovo Presents New Preclinical Data on 3D Bioprinted Human Liver Tissues for the Treatment of Inborn Errors of Metabolism at The Liver Meeting® 2017 (AASLD)By Nasdaq OMXOct 20, 2017, 12:05 PM UTC
BusinessNewLink Genetics to Host Its Third Quarter 2017 Financial Results Conference Call on November 2, 2017By Nasdaq OMXOct 20, 2017, 12:00 PM UTC
BusinessImmune Design Announces G100’s Receipt of Orphan Drug Designation by the EMA for the Treatment of Follicular Non-Hodgkin’s LymphomaBy Nasdaq OMXOct 19, 2017, 8:05 PM UTC
BusinessOrganovo Announces Release Date for Fiscal Second-Quarter 2018 Financial ResultsBy Nasdaq OMXOct 19, 2017, 12:05 PM UTC
BusinessNovel Preclinical Research Tools Provide Humanized Immune Response to Advance Immunotherapeutic Development, Live Webinar Hosted by Crown BioscienceBy Nasdaq OMXOct 19, 2017, 12:00 PM UTC
BusinessGeneSight® Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine UseBy Nasdaq OMXOct 19, 2017, 11:05 AM UTC
BusinessBioAegis Therapeutics and the T.H. Chan-Harvard School of Public Health Demonstrate “Delayed Therapy with Plasma Gelsolin Improves Survival in Murine Pneumococcal Pneumonia” at ID WeekBy Nasdaq OMXOct 18, 2017, 5:34 PM UTC
BusinessBeyondSpring Chief Medical Officer to Present at the 2017 BIO Investor Forum on Oct. 18 in San FranciscoBy Nasdaq OMXOct 18, 2017, 12:30 PM UTC
